ASTL and pancreatic neoplasm: The flow cytometry data coupled with the cytotoxicity data shown in Figure 4 suggests that a limited pool of cell surface-associated SAS1B may be sufficient to induce cell death when SAS1Bpos pancreatic cancer cells are targeted with an anti-SAS1B ADC.